Metabolomics Market To Grow at CAGR 13.2%, Market Value to Reach USD 8.3 Billion By 2032
Acumen Research and Consulting has announced the addition of the “Metabolomics Market” report to their offering.
The Metabolomics Market Industry Report 2030 is an in depth study analyzing the current state of the Metabolomics Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Metabolomics Market provides analysis of China market covering the industry trends, recent developments in the market and competitive landscape.
Competitive analysis includes competitive information of leading players in China market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Metabolomics Market also discusses the opportunity areas for investors.
Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/374
The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Some of the global Metabolomics companies profiled in the report include Thermo Fisher Scientific Inc., Biocrates Life Sciences AG, Human Metabolome Technologies Inc., Metabolon Inc., Bruker Corporation, LECO Corporation, Waters Corporation, Agilent Technologies, Bio-Rad laboratories Inc., Shimadzu Corporation.
Market Segmentation:
Metabolomics Market By Product & Service
- Metabolomics Instruments
- Metabolomics Bioinformatics Tools & Service
Metabolomics Market By Indication
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Inborn Errors of Metabolism
- Others
Metabolomics Market By Application
- Biomarker Discovery
- Drug Discovery
- Toxicology Testing
- Nutrigenomics
- Functional Genomics
- Personalized Medicine
- Others
Metabolomics Market By End-Use
- Academic Research & Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Others
Table Of Contents:
CHAPTER 1. Industry Overview of Metabolomics Market
1.1. Definition and Scope
1.1.1. Definition of Metabolomics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Metabolomics Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Metabolomics Market By Product & Service
1.2.3. Metabolomics Market By Indication
1.2.4. Metabolomics Market By Application
1.2.5. Metabolomics Market By End-Use
1.2.6. Metabolomics Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Metabolomics Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Metabolomics Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Flooring & Wall Panels Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Metabolomics Market By Product & Service
5.1. Introduction
5.2. Metabolomics Market Revenue By Product & Service
5.2.1. Metabolomics Market Revenue (USD Billion) and Forecast, By Product & Service, 2020-2032
5.2.2. Metabolomics Instruments
5.2.2.1. Metabolomics Instruments Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Metabolomics Bioinformatics Tools & Service
5.2.3.1. Metabolomics Bioinformatics Tools & Service Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Metabolomics Market By Indication
6.1. Introduction
6.2. Metabolomics Market Revenue By Indication
6.2.1. Metabolomics Market Revenue (USD Billion) and Forecast, By Indication, 2020-2032
6.2.2. Cancer
6.2.2.1. Cancer Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Cardiovascular Disorders
6.2.3.1. Cardiovascular Disorders Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Neurological Disorders
6.2.4.1. Neurological Disorders Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.5. Inborn Errors of Metabolism
6.2.5.1. Inborn Errors of Metabolism Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.6. Others
6.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Metabolomics Market By Application
7.1. Introduction
7.2. Metabolomics Market Revenue By Application
7.2.1. Metabolomics Market Revenue (USD Billion) and Forecast, By Application, 2020-2032
7.2.2. Biomarker Discovery
7.2.2.1. Biomarker Discovery Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Drug Discovery
7.2.3.1. Drug Discovery Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Toxicology Testing
7.2.4.1. Toxicology Testing Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.5. Nutrigenomics
7.2.5.1. Nutrigenomics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.6. Functional Genomics
7.2.6.1. Functional Genomics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.7. Personalized Medicine
7.2.7.1. Personalized Medicine Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.8. Others
7.2.8.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. Metabolomics Market By End-Use
8.1. Introduction
8.2. Metabolomics Market Revenue By End-Use
8.2.1. Metabolomics Market Revenue (USD Billion) and Forecast, By End-Use, 2020-2032
8.2.2. Academic Research & Institutes
8.2.2.1. Academic Research & Institutes Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.3. Pharmaceutical & Biotechnology Companies
8.2.3.1. Pharmaceutical & Biotechnology Companies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.4. Contract Research Organizations
8.2.4.1. Contract Research Organizations Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.5. Others
8.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 9. North America Metabolomics Market By Country
9.1. North America Metabolomics Market Overview
9.2. U.S.
9.2.1. U.S. Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
9.2.2. U.S. Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.2.3. U.S. Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
9.2.4. U.S. Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
9.3. Canada
9.3.1. Canada Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
9.3.2. Canada Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.3.3. Canada Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
9.3.4. Canada Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe Metabolomics Market By Country
10.1. Europe Metabolomics Market Overview
10.2. U.K.
10.2.1. U.K. Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
10.2.2. U.K. Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.2.3. U.K. Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
10.2.4. U.K. Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
10.3. Germany
10.3.1. Germany Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
10.3.2. Germany Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.3.3. Germany Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
10.3.4. Germany Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
10.4. France
10.4.1. France Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
10.4.2. France Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.4.3. France Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
10.4.4. France Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
10.5. Spain
10.5.1. Spain Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
10.5.2. Spain Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.5.3. Spain Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
10.5.4. Spain Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
10.6.2. Rest of Europe Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.6.3. Rest of Europe Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
10.6.4. Rest of Europe Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia-Pacific Metabolomics Market By Country
11.1. Asia-Pacific Metabolomics Market Overview
11.2. China
11.2.1. China Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
11.2.2. China Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.2.3. China Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
11.2.4. China Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.3. Japan
11.3.1. Japan Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
11.3.2. Japan Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.3.3. Japan Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
11.3.4. Japan Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.4. India
11.4.1. India Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
11.4.2. India Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.4.3. India Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
11.4.4. India Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.5. Australia
11.5.1. Australia Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
11.5.2. Australia Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.5.3. Australia Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
11.5.4. Australia Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.6. South Korea
11.6.1. South Korea Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
11.6.2. South Korea Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.6.3. South Korea Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
11.6.4. South Korea Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
11.7.2. Rest of Asia-Pacific Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.7.3. Rest of Asia-Pacific Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
11.7.4. Rest of Asia-Pacific Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.8. Asia-Pacific PEST Analysis
CHAPTER 12. Latin America Metabolomics Market By Country
12.1. Latin America Metabolomics Market Overview
12.2. Brazil
12.2.1. Brazil Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
12.2.2. Brazil Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
12.2.3. Brazil Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
12.2.4. Brazil Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
12.3. Mexico
12.3.1. Mexico Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
12.3.2. Mexico Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
12.3.3. Mexico Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
12.3.4. Mexico Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
12.4.2. Rest of Latin America Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
12.4.3. Rest of Latin America Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
12.4.4. Rest of Latin America Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Metabolomics Market By Country
13.1. Middle East & Africa Metabolomics Market Overview
13.2. GCC
13.2.1. GCC Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
13.2.2. GCC Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
13.2.3. GCC Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
13.2.4. GCC Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
13.3. South Africa
13.3.1. South Africa Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
13.3.2. South Africa Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
13.3.3. South Africa Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
13.3.4. South Africa Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Metabolomics Market Revenue (USD Billion) and Forecast By Product & Service, 2020-2032
13.4.2. Rest of Middle East & Africa Metabolomics Market Revenue (USD Billion) and Forecast By Indication, 2020-2032
13.4.3. Rest of Middle East & Africa Metabolomics Market Revenue (USD Billion) and Forecast By Application, 2020-2032
13.4.4. Rest of Middle East & Africa Metabolomics Market Revenue (USD Billion) and Forecast By End-Use, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Metabolomics Market
14.1. Metabolomics Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by Product & Service, presence, market share, and R&D investment
14.2.2. New Product & Service Launches and Product & Service Enhancements
14.2.3. Mergers And Acquisition In Global Metabolomics Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Thermo Fisher Scientific Inc.
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Billion), 2022
15.1.3.2. Thermo Fisher Scientific Inc. 2022 Metabolomics Business Regional Distribution
15.1.4. Product & Service/Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Biocrates Life Sciences AG
15.3. Human Metabolome Technologies Inc.
15.4. Metabolon Inc.
15.5. Bruker Corporation
15.6. LECO Corporation
15.7. Waters Corporation
15.8. Agilent Technologies
15.9. Bio-Rad laboratories Inc.
15.10. Shimadzu Corporation
Ask Query Here: Richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com
To Purchase this Premium Report@https://www.acumenresearchandconsulting.com/buy-now/0/374
About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
